alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# Fourth Court of Appeals **San Antonio, Texas** MEMORANDUM OPINION
N o. 04

- 16

- 00682

- CV IN THE INTEREST OF A.P.R. and J.C.R., Children From the 224th Judicial District Court, Bexar County, Texas Trial Court No. 2016

- CI

- 06574 Honorable Michael E. Mery, Judge Presiding
PER CURIAM Sitting: Sandee Bryan Marion, Chief Justice Luz Elena D. Chapa, Justice Jason Pulliam, Justice Delivered and Filed: December 7, 2016
DIS MISSED When Abel Castillo Rodriguez filed this appeal on October 17, 2016 , he was required to pay a $205.00 filing fee. See T EX
. R. A PP
. 5; T EXAS S UPREME C OURT O RDER R EGARDING F EES C HARGED I N C IVIL C ASES I N THE S UPREME C OURT AND THE C OURTS OF A PPEALS AND B EFORE THE J UDICIAL P ANEL ON M ULTIDISTRICT L ITIGATION (Misc. Docket No. 159158, Aug. 28, 2015). Appellant did not pay the re quired filing fee; accordingly, the clerk of this court notified him by letter that his notice of appeal was conditionally filed and the filing fee was due October 31, 2016.
On November 16, 2016, when the fee remained unpaid, this court ordered that Rodri guez must, not later than November 28, 2016, either (1) pay the applicable filing fee or (2) provide written proof to this court that he is indigent or otherwise excused by statute or the Texas Rules of Appellate Procedure from paying the fee. See T EX
. R. A PP
. P. 5 (“A party who is not excused by04

- 16

- 00682

- CV

- 2

- statute or these rules from paying costs must pay

— at the time an item is presented for filing

— whatever fees are required by statute or Supreme Court order. The appellate court may enforce this rule by any order t hat is just.”). The court advised Rodriguez that if he failed to respond satisfactorily within the time ordered, the appeal would be dismissed. See T EX
. R. A PP
. P. 42.3. The filing fee has not been paid, and Rodriguez has not otherwise responded to our
N ovember 16 order. We therefore dismiss this appeal for want of prosecution.
PER CURIAM
#### Rick Friedman, Appellant, v Park Cake, Inc., Individually and Doing Business as L’Express, L’Express, et al., Defendants. Mark E. Seitelman, P.C., et al., Nonparty Respondents.

[825 NYS2d 11]

Order, Supreme Court, New York County (Marilyn Shafer, J.), entered July 27, 2005, which granted counsel’s motion to withdraw, distribute settlement funds in his possession and receive his legal fee and disbursements, unanimously affirmed, without costs.

Plaintiff agreed to a $90,000 settlement in this personal injury action, but sought to deny compensation to his attorney for the latter’s failure to inform him of a medical lien that purportedly reduced his monetary recovery. He argued that this oversight constituted legal misconduct warranting his discharge of counsel for cause.

It is well settled that a client may terminate his relationship with an attorney at any time, with or without cause (see *287*Campagnola v Mulholland, Minion & Roe,*76 NY2d 38, 43 [1990]). “Where the discharge is for cause, the attorney has no right to compensation or a retaining lien, notwithstanding a specific retainer agreement” *{id.*at 44). Ordinarily, conflicting claims would necessitate a hearing to determine whether an outgoing attorney was discharged with or without cause *(see Teichner v W & J Holsteins,*64 NY2d 977, 979 [1985]). Here, however, plaintiff did not seek termination for cause until after the attorney had already completed his services and had obtained a settlement that was even more favorable than the trial court anticipated.

Both the retainer agreement and the firm’s “General Instructions to Our Clients” discussed plaintiff’s responsibility for hens, explaining that they would be deducted from any recovery. Plaintiff takes the position that before he accepted the settlement offer, he had no responsibility to question his attorney regarding the breakdown of disbursements, counsel fees or any hens, to obtain an idea what his recovery would be. Instead, he complains that counsel failed to come forward and volunteer information about this particular hen prior to the settlement. While it undoubtedly would be preferable for counsel to identify and discuss any specific hens on a plaintiffs settlement, regardless of whether the client affirmatively asked for that information, the failure to do so is not grounds for depriving counsel of an earned legal fee. We note that at the outset of their attorney-client relationship, defendant law firm clearly warned plaintiff that various hens would be deducted from the ultimate recovery, albeit without specifying a specific hen applicable to the underlying lawsuit. Furthermore, in the absence of any identifiable duty to his chent that counsel purportedly breached, the motion court appropriately determined that no hearing was warranted on the question of termination for cause, and plaintiff established no basis for depriving counsel of his fee. Concur—Mazzarelli, J.B, Saxe, Marlow, Sullivan and Williams, JJ.
```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[S.J. Res. 45 Introduced in Senate (IS)]

<DOC>

116th CONGRESS
  1st Session
S. J. RES. 45

Providing for congressional disapproval of the proposed transfer to the 
     Kingdom of Saudi Arabia certain defense articles and services.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              June 5, 2019

Mr. Menendez (for himself, Mr. Graham, Mr. Murphy, Mr. Paul, Mr. Leahy, 
  Mr. Young, and Mr. Reed) introduced the following joint resolution; 
which was read twice and referred to the Committee on Foreign Relations

_______________________________________________________________________

                            JOINT RESOLUTION

 
Providing for congressional disapproval of the proposed transfer to the 
     Kingdom of Saudi Arabia certain defense articles and services.

    Resolved by the Senate and House of Representatives of the United 
States of America in Congress assembled, That the issuance of an export 
license with respect to the following proposed exports to the Kingdom 
of Saudi Arabia is prohibited:
            (1) The transfer of the following defense articles, 
        including services and technical data, described in Executive 
        Communication 1416 (EC-1416) submitted to Congress pursuant to 
        section 36(c) of the Arms Export Control Act (22 U.S.C. 
        2776(c)) and published in the Congressional Record on June 3, 
        2019: The proposed export of 15,000 120mm M933A1 mortar bombs 
        to Saudi Arabia for end use by the Royal Land Forces of the 
        Kingdom of Saudi Arabia.
                                 <all>
```
#### Powell *v.*Allen & Holmes.

February 24, 1910.

Complaint.

Before Judge Mitchell.

Colquitt superior court.

October 15, 1908.

*Shipp & Kline,*for plaintiff.

*J. A. Wilkes*and *W. A. Covington,*for defendants.

Holden, J.

Under the ruling made in this case when it was formerly before this court *(Allen & Holmes*v. *Powell,*125 *Ga.*438 (54 S. E. 137) ), the amendments made by the plaintiff did not cure the defects held to exist in his petition, and under such ruling the court committed no error in dismissing the petition.

*Judgment affirmed.*

*All the Justices concur.*
```

                                                                    Exhibit 99.1

                    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350

     In connection with the accompanying Amended Annual Report on Form 10-K/A of
Energy West Incorporated for the fiscal year ended June 30, 2002, I, Edward J.
Bernica, Chief Executive Officer of Energy West Incorporated, hereby certify
pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the
Sarbanes-Oxley Act of 2002, that to my knowledge:

     (1) such Amended Annual Report on Form 10-K/A for the fiscal year ended
June 30, 2002 fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

     (2) the information contained in such Amended Annual Report on Form 10-K/A
for the fiscal year ended June 30, 2002 fairly presents, in all material
respects, the financial condition and results of operations of Energy West
Incorporated.

Date: November 25, 2002                    /s/ Edward J. Bernica
                                           -------------------------------------
                                           Edward J. Bernica,
                                           President and Chief Executive Officer
                                           (principal executive officer)
```
UNITED STATES OF AMERICA

before the

SECURITIES AND EXCHANGE COMMISSION

SECURITIES EXCHANGE ACT OF 1934

Release No. 86243 / June 28, 2019

Admin. Proc. File No. 3-18141

In the Matter of 

CELLCYTE GENETICS CORP. and

CHINA PEDIATRIC PHARMACEUTICALS, INC. 

NOTICE THAT INITIAL DECISION HAS BECOME FINAL

The time for filing a petition for review of the initial decision in this proceeding has 

expired. No such petition has been filed by CellCyte Genetics Corp. or China Pediatric 

Pharmaceuticals, Inc., and the Commission has not chosen to review the decision on its own 

initiative.

Accordingly, notice is hereby given, pursuant to Rule 360(d) of the Commission's Rules 

of Practice,1that the initial decision of the administrative law judge has become the final 

decision of the Commission with respect to CellCyte Genetics Corp. and China Pediatric 

Pharmaceuticals, Inc.

2

The order contained in that decision is hereby declared final. The initial 

decision ordered that, pursuant to Section 12(j) of the Securities Exchange Act of 1934, the 

registrations of each class of registered securities of CellCyte Genetics Corp. and China Pediatric 

Pharmaceuticals, Inc., are revoked. The revocation is effective as of July 1, 2019.

For the Commission, by the Office of the General Counsel, pursuant to delegated 

authority.

Vanessa A. Countryman

 Secretary

 

1

 17 C.F.R. § 201.360(d).

2

 CellCyte Genetics Corp., China Pediatric Pharm., Inc., and Hawker Energy, Inc., Initial 

Decision Release No. 1368 (Mar. 18, 2019), 2019 WL 1239734. The Central Index Key 

numbers are: 1325279 for CellCyte Genetics Corp.; and 1354071 for China Pediatric 

Pharmaceuticals, Inc.
### §361c–1. Omitted

#### **Editorial Notes**

#### Codification

Section, act June 15, 1936, ch. 554, §2, as added Aug. 10, 1939, ch. 639, 53 Stat. 1342, appropriated $8,000 for purchase of lands described in section 361c of this title.
Exhibit 11

                              TFC ENTERPRISES, INC.
             SCHEDULE OF COMPUTATION OF NET INCOME PER COMMON SHARE
                (Dollars in thousands, except per share amounts)
<TABLE>
<CAPTION>


                                                                                                Years ended December 31

                                                                              1996                     1995                    1994
                                                                              ----                     ----                    ----
<S> <C>
PRIMARY:

Net income (loss)                                                    $      (7,596)            $     (6,461)           $      7,231
                                                                     =============            =============           =============

Weighted average shares outstanding                                     11,289,558               11,282,897              11,225,100

Add incremental shares related to stock options                                  -                                            6,210
                                                                  -----------------         ---------------         ---------------
                                                                        11,289,558               11,282,897              11,231,310
                                                                  -----------------         ---------------         ---------------
Net income (loss) per common share                                  $        ( .67)          $        ( .57)         $          .64
                                                                   ===============          ===============         ===============


FULLY DILUTED:

Net income                                                                                                            $       7,231
                                                                                                                         ----------
Average shares outstanding                                                                                               11,225,100

Add incremental shares related to stock options                                                                               6,674
                                                                                                                         ----------
                                                                                                                         11,231,774
                                                                                                                         ----------
Fully diluted net income per common share                                                                           $           .64
                                                                                                                    ===============
</TABLE>
### §§117a, 117b. Repealed. June 25, 1948, ch. 646, §39, 62 Stat. 992, eff. Sept. 1, 1948

Section 117a, act Apr. 25, 1928, ch. 434, §2, 45 Stat. 459, related to inclusion of park in a judicial district. See section 85 of Title 28, Judiciary and Judicial Procedure.

Section 117b, act Apr. 25, 1928, ch. 434, §3, 45 Stat. 459, related to applicability of Colorado laws to offenses. See section 13 of Title 18, Crimes and Criminal Procedure.
#### William A. Montgomery, Respondent, v. Morris Plan Industrial Bank of New York, Appellant.

Close, P. J., Hagarty, Carswell, Taylor and Lewis, JJ., concur.
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration
 Pursuant to § 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on November 9, 2010, Mallinckrodt, Inc., 3600 North Second Street, St. Louis, Missouri 63147, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: Drug
ScheduleTetrahydrocannabinols (7370)
ICodeine-N-oxide (9053)
IDihydromorphine (9145)
IDifenoxin (9168)
IMorphine-N-oxide (9307)
INormorphine (9313)
INorlevorphanol (9634)
IAmphetamine (1100)
IIMethamphetamine (1105)
IIMethylphenidate (1724)
IINabilone (7379)
IICodeine (9050)
IIDiprenorphine (9058)
IIEtorphine HCl (9059)
II( print page 14690)Dihydrocodeine (9120)
IIOxycodone (9143)
IIHydromorphone (9150)
IIDiphenoxylate (9170)
IIEcgonine (9180)
IIHydrocodone (9193)
IILevorphanol (9220)
IIMeperidine (9230)
IIMethadone (9250)
IIMethadone intermediate (9254)
IIMetopon (9260)
IIDextropropoxyphene, bulk (9273)
IIMorphine (9300)
IIOripavine (9330)
IIThebaine (9333)
IIOpium extracts (9610)
IIOpium fluid extract (9620)
IIOpium tincture (9630)
IIOpium, powdered (9639)
IIOpium, granulated (9640)
IILevo-alphacetylmethadol (9648)
IIOxymorphone (9652)
IINoroxymorphone (9668)
IIAlfentanil (9737)
IIRemifentanil (9739)
IISufentanil (9740)
IIFentanyl (9801)
II
 The firm plans to manufacture the listed controlled substances for internal use and for sale to other companies. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than May 16, 2011. Dated: March 9, 2011. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.


[FR Doc. 2011-6157 Filed 3-16-11; 8:45 am] BILLING CODE 4410-09-P
[if !vml]>[endif]>

[if !vml]>[endif]>

You have reached the FederalDepository Library Program Electronic Collection (FDLP/EC) Archive. Thisarchive assures ongoing access to publications in the FDLP/EC. Access topublications in the archive is available through GPO's suite of cataloging andlocator services, including the Catalog of U.S. Government Publications(CGP).  Archived copies of publications are retrieved in the event thatpublications are no longer available from the original publishing agency site. 
**Title: Motorvehicle use map, Tahoe National Forest, Truckee Ranger District, California**
 
Front | Back
 
SuDoc Number:A 13.28:T 13/9/2013
Item Number:0080-G (online)
CGP systemNumber:000955368
 
May 31, 2018
Manatili sa bahay kapag ikaw ay 

maysakit, maliban para humingi 

ng pangangalagang medikal.

Hugasan ang iyong mga kamay nang 

madalas gamit ang sabon at tubig 

nang hindi bababa sa 20 segundo.

Takpan ng tisyu ang iyong pag-ubo

o pagbahing, pagkatapos

ay itapon ang tisyu 

sa basurahan.

Linisin at disimpektahin ang madalas 

na hinahawakang mga bagay at ibabaw.

Iwasang hawakan 

ang iyong mata, 

ilong, at bibig. 

Iwasan ang malapitang pakikipag-ugnayan sa 

mga taong maysakit. 

Kapag nasa publiko, 

magsuot ng telang 

pantakip na tumatakip sa 

iyong ilong at bibig.

Tumulong na maiwasan ang pagkalat ng mga sakit sa paghinga tulad ng COVID-19.

Itigil ang Pagkalat ng Mikrobyo

cdc.gov/coronavirus

316351-Y May 5, 2020 2:31 PM
MANDATE

Court of Appeals 

First District of Texas 

NO. 01-13-01091-CV

JUDITH KING, INDIVIDUALLY AND AS INDEPENDENT EXECUTOR OF THE

ESTATE OF KENNETH KING, Appellants

V.

DEUTSCHE BANK NATIONAL TRUST COMPANY, AS INDENTURE TRUSTEE, 

ON BEHALF OF THE OWNERS OF ACCREDITED MORTGAGE LOAN TRUST 

2004-4 ASSET BACKED NOTES, BY ITS ATTORNEY-IN-FACT AND SERVICERIN-FACT, SELECT PORTFOLIO SERVICING, INC., Appellee

Appeal from the 281st District Court of Harris County. (Tr. Ct. No. 2012-36457).

TO THE 281ST DISTRICT COURT OF HARRIS COUNTY, GREETINGS:

Before this Court, on the 18th day of August 2015, the case upon appeal to revise 

or to reverse your judgment was determined. This Court made its order in these words:

This case is an appeal from the final judgment signed 

by the trial court on October 3, 2013. After submitting the 

case on the appellate record and the arguments properly 

raised by the parties, the Court holds that the trial court 

lacked subject-matter jurisdiction over the case. Accordingly,

the Court vacates the trial court’s judgment and dismisses the 

case.
The Court orders that the appellee, Deutsche Bank 

National Trust Company, as Indenture Trustee, on behalf of 

the Owners of Accredited Mortgage Loan Trust 2004-4 Asset 

Backed Notes, by its Attorney-in-Fact and Servicer-in-Fact, 

Select Portfolio Servicing, Inc., pay all appellate costs.

The Court orders that this decision be certified below 

for observance.

Judgment rendered August 18, 2015.

Panel consists of Justices Jennings, Higley, and Huddle. 

Opinion delivered by Justice Huddle.

WHEREFORE, WE COMMAND YOU to observe the order of our said Court 

in this behalf and in all things to have it duly recognized, obeyed, and executed.

October 30, 2015 

Date CHRISTOPHER A. PRINE

 CLERK OF THE COURT
§ 7.3 Adequacy review of application. ( a ) *Adequacy review of license applications.* Review of the original license application for which expedited processing under this part is requested will be conducted pursuant to 18 CFR part 4 or 5, as applicable.
( b ) *Deficient license applications.* If an original license application for which expedited processing is requested under this part is rejected under 18 CFR parts 4 and 5, as applicable, the request for authorization for the expedited licensing process under this part is deemed rejected.
July 13th, 2015

U.S. Department of Transportation Docket Management System 1200 New Jersey Ave., SE Washington, DC 20590

RE: Amendment to Exemption 11426 issued pursuant to Section 333 of the FAA Reform Act and Part 11 of the Federal Aviation Regulations in Regulatory Docket NO. FAA-2015-0173

Dear Sir or Madam:

Alaska Aerial Media LLC. was issued an Exemption numbered 11426 (hereinafter the Exemption) for the purpose of aerial cinematography and videography, as well as implementation of emergency use UAS systems with public entities. Alaska Aerial Media requests an amendment to the exemption to allow for three (1) additional type of unmanned aircraft system (UAS) that fully comply with the conditions of the Exemption.

Alaska Aerial Media LLC. wishes to operate the Trimble UX5 fixed wing under the same conditions contained in the exemption. Attached hereto are the Flight Operations and Procedures Manuals (FOPM) for the one (1) additional UAS. All operations of the additional UAS will be in full compliance with the terms of the Exemption.

Please contact the undersigned should you have any questions concerning this request for amendment to the Exemption.

Sincerely,

Ryan P. Marlow Alaska Aerial Media 7960 Upper OMalley Road Anchorage Alaska 99507 Tele: (907)-717-9794
[if !vml]>[endif]>

[if !vml]>[endif]>

You have reached the FederalDepository Library Program Electronic Collection (FDLP/EC) Archive. Thisarchive assures ongoing access to publications in the FDLP/EC. Access to publicationsin the archive is available through GPO's suite of cataloging and locatorservices, including the Catalog of U.S. Government Publications (CGP). Archived copies of publications are retrieved in the event that publicationsare no longer available from the original publishing agency site. 
**Title:****Central flyway harvest andpopulation survey data book [electronic resource].
 
2004 | 2005
2010 | 2012 | 2015 | 2017 | 2018 | 2019
2020 | 2022
 
SuDoc Number:I 49.44/5:F 67/

Item Number: 0612-C-03 (online)

CGP systemNumber:000621307 
October 29, 2018**